Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityNo recent work listed

Yuwei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9290-6701; OpenAlex author ID A5100331392. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes. Co-author DOI 10.1002/jmv.28108↗
  2. Oncolytic virotherapy in hepato-bilio-pancreatic cancer: The key to breaking the log jam? Co-author DOI 10.1002/cam4.2949↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yinan Shen · 2 shared papers, 2020–2023 · strength 0.27
  2. Tingbo Liang · 2 shared papers, 2020–2023 · strength 0.27
  3. Xueli Bai · 2 shared papers, 2020–2023 · strength 0.27
  4. Xiaozhen Zhang · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.